SCHEMBL3775503

SCHEMBL3775503

C=CNN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4393369 0.67
SCHEMBL16591163 0.67
SCHEMBL1360517 0.67
SCHEMBL28232526 0.62
Ethylene SCHEMBL28455569 0.60
SCHEMBL17599028 0.59
SCHEMBL29053417 0.59
SCHEMBL11129667 0.59
SCHEMBL576753 0.59
SCHEMBL28003704 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 147 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11389545-B2 Bioactive nanoparticles and methods for making same AQUA REGENERATIVE THERAPIES LLC 2022-07-19 US claimed
US-10815212-B2 Cytotoxin compounds and methods of isolation UNIVERSITY OF SOUTH FLORIDA (US) 2020-10-27 US claimed
US-20160297790-A1 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION UNIV SOUTH FLORIDA (US) 2016-10-13 US claimed
US-20140194495-A1 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION THE UAB RESEARCH FOUNDATION (US) 2014-07-10 US claimed
US-8669376-B2 Cytotoxin compounds and methods of isolation UNIVERSITY OF SOUTH FLORIDA (US) 2014-03-11 US claimed
US-20100255465-A1 Nucleic Acid-Polymer Particle for and Method of Tracing Movement of a Liquid ENVIROGENE LTD. 2010-10-07 US claimed
US-20090192215-A1 Cytotoxin Compounds and Methods of Isolation UNIVERSITY OF SOUTH FLORIDA (US) 2009-07-30 US claimed
CN-101479214-A Composition for coloring ceramic articles GRAZIANO VIGNALI (IT) 2009-07-08 CN claimed
EP-2029770-A2 A NUCLEIC ACID - POLYMER PARTICLE FOR AND METHOD OF TRACING MOVEMENT OF A LIQUID Envirogene, Ltd. (GB) 2009-03-04 EP claimed
EP-1934196-A2 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION University of South Florida (US) 2008-06-25 EP claimed
WO-2007148058-A2 A NUCLEIC ACID-POLYMER PARTICLE FOR AND METHOD OF TRACING MOVEMENT OF A LIQUID ENVIROGENE LTD (GB) 2007-12-27 WO claimed
US-7268199-B2 Use of alkoxylated polyvinyl amines for the modification of surfaces BASF AKTIENGESELLSCHAFT (DE) 2007-09-11 US claimed
WO-2007035734-A2 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION UNIVERSITY OF SOUTH FLORIDA (US) 2007-03-29 WO claimed
EP-1290071-B1 USE OF ALKOXYLATED POLYVINYL AMINES FOR THE MODIFICATION OF SURFACES BASF AG (DE) 2005-05-11 EP claimed
US-20030143908-A1 Use of alkoxylated polyvinyl amines for the modification of surfaces BASF AKTIENGESELLSCHAFT (DE) 2003-07-31 US claimed
US-6413941-B1 ANTICANCER AGENTS WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINICAL RESEARCH CENTRE LIMITED (GB) 2002-07-02 US claimed
EP-0871491-A2 POLYMERS DANBIOSYST UK LIMITED (GB) 1998-10-21 EP claimed
WO-1997025067-A2 POLYMERS DANBIOSYST UK LIMITED (GB) 1997-07-17 WO claimed
US-4122046-A OF ACRYLAMIDE, METAL COMPLEX CATALYST MAXICHEM, INC., A CORP. OF NC 1978-10-24 US claimed
WO-2023182073-A1 LUBRICATING OIL COMPOSITION 出光興産株式会社 2023-09-28 WO disclosed
US-20230270870-A1 DOSAGE OF AN ANTIBODY-DRUG CONJUGATE DAIICHI SANKYO COMPANY, LIMITED (JP) 2023-08-31 US disclosed
EP-3495398-B1 COPOLYMER, AS WELL AS SEPARATION MEMBRANE, MEDICAL DEVICE, AND BLOOD PURIFIER IN WHICH SAID COPOLYMER IS USED TORAY INDUSTRIES (JP) 2023-07-19 EP disclosed
CN-113845481-B Synthesis method of 4, 4-dimethyl-4, 5-dihydropyridazin-3-one 泉州师范学院 2023-05-30 CN disclosed
CN-112805312-B Catalyst for PIR/PUR foam production 亨茨曼国际有限公司 2023-03-21 CN disclosed
US-11389545-B2 Bioactive nanoparticles and methods for making same AQUA REGENERATIVE THERAPIES LLC 2022-07-19 US disclosed
WO-2022140554-A1 SMALL MOLECULE DEGRADERS OF PHOSPHATIDYLINOSITOL-5-PHOSPHATE 4-KINASE TYPE 2 AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-06-30 WO disclosed
CN-113845481-A Synthesis method of 4, 4-dimethyl-4, 5-dihydropyridazin-3-one 泉州师范学院 2021-12-28 CN disclosed
CN-109476786-B Copolymer, and separation membrane, medical device, and blood purifier using same 东丽株式会社 2021-08-03 CN disclosed
EP-2966108-B1 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS SAUDI ARAMCO TECH CO (SA) 2021-03-31 EP disclosed
US-20210011200-A1 FUNCTIONAL CONTACT LENS AND METHOD FOR DYEING THE SAME VIZIONFOCUS INC. (TW) 2021-01-14 US disclosed
WO-2020252205-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY Praxis Biotech LLC (US) 2020-12-17 WO disclosed
WO-2020240034-A1 HYALURONIC ACID-BASED HYBRID HYDROGEL UNIVERSITY COLLEGE DUBLIN (IE) 2020-12-03 WO disclosed
US-10815212-B2 Cytotoxin compounds and methods of isolation UNIVERSITY OF SOUTH FLORIDA (US) 2020-10-27 US disclosed
WO-2020146888-A1 MICROBIOME ENGINEERING THROUGH ENGINEERED MOBILE GENETIC ELEMENTS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2020-07-16 WO disclosed
WO-2020108500-A1 HISTONE ACETYLASE P300 INHIBITOR AND USE THEREOF 成都海创药业有限公司 2020-06-04 WO disclosed
WO-2020036986-A1 THIADIAZOLE IRAK4 INHIBITORS GILEAD SCIENCES, INC. (US) 2020-02-20 WO disclosed
US-20190292288-A1 COPOLYMER, SEPARATION MEMBRANE, MEDICAL DEVICE, AND BLOOD PURIFIER USING THE COPOLYMER TORAY INDUSTRIES, INC. (JP) 2019-09-26 US disclosed
US-20190209705-A1 BIOACTIVE NANOPARTICLES AND METHODS FOR MAKING SAME AQUA REGENERATIVE THERAPIES LLC 2019-07-11 US disclosed
EP-3495398-A1 COPOLYMER, AS WELL AS SEPARATION MEMBRANE, MEDICAL DEVICE, AND BLOOD PURIFIER IN WHICH SAID COPOLYMER IS USED Toray Industries, Inc. (JP) 2019-06-12 EP disclosed
CN-105505618-B Copolymer and preparation method thereof containing sulfonate group 宝洁公司 2019-05-07 CN disclosed
WO-2019036665-A1 COMPOSITIONS COMPRISING AROMATIC ESTER SOLVENTS FOR USE IN OIL AND/OR GAS WELLS AND RELATED METHODS FLOTEK CHEMISTRY, LLC (US) 2019-02-21 WO disclosed
CN-109235052-A Non-durable fibers net 霍林斯沃思和沃斯有限公司 2019-01-18 CN disclosed
CN-109072556-A The method for manufacturing paper 凯米罗总公司 2018-12-21 CN disclosed
WO-2018024902-A1 USES OF HYDROPHOBICALLY-MODIFIED HYALURONIC ACID THROUGH AMIDE AND/OR HYDRAZIDE LINKAGES IN COSMETICS AND/OR DERMATOLOGY BIOKAWTHAR TECHNOLOGIES (FR) 2018-02-08 WO disclosed
CN-107591582-A method for recycling lithium ion battery 皓智环球有限公司 2018-01-16 CN disclosed
WO-2017165299-A2 COMPANION DIAGNOSTIC TOOL FOR PEPTIDOMIMETIC MACROCYCLES AILERON THERAPEUTICS, INC. (US) 2017-09-28 WO disclosed
CN-107106954-A Resin impregnated fibrous web 霍林斯沃思和沃斯有限公司 2017-08-29 CN disclosed
US-9738624-B2 Nuclear transport modulators and uses thereof Karyopharm Therapeutics Inc. (US) 2017-08-22 US disclosed
CN-106807336-A With reference to the ion containing metal or the porous polymer material for purifying organic molecule 指示行动股份有限公司 2017-06-09 CN disclosed
US-20170008915-A1 ACID, SOLVENT, AND THERMAL RESISTANT METAL-ORGANIC FRAMEWORKS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2017-01-12 US disclosed
US-20160369293-A1 PLANTS HAVING IMPROVED CHARACTERISTICS AND METHOD FOR MAKING THE SAME CROPDESIGN N.V. (BE) 2016-12-22 US disclosed
EP-3100745-A1 NOVEL BENZODIAZEPINE DERIVATIVES Immunogen, Inc. (US) 2016-12-07 EP disclosed
US-20160317590-A1 Antibacterial Phage, Phage Peptides And Methods Of Use Thereof TECHNOPHAGE, INVESTIGACAO E DESENVOLVIMENTO EM BIOTECNOLOGIA, S.A. (PT) 2016-11-03 US disclosed
US-9475872-B2 Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17F IMMUNOQURE AG (DE) 2016-10-25 US disclosed
US-20160297790-A1 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION UNIV SOUTH FLORIDA (US) 2016-10-13 US disclosed
EP-2563790-B1 A PROCESS OF A QUATERNARY AMMONIUM SALT SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2016-09-14 EP disclosed
CN-105925056-A Water-based ink for tipping paper intaglio printing and preparation method of water-based ink 江苏唐彩油墨科技股份有限公司 2016-09-07 CN disclosed
CN-103492425-B The preparation method of the polymer containing acylated vinylamine and the application as additive for paper making thereof 索理思科技开曼公司 2016-08-31 CN disclosed
US-20160249439-A1 COORDINATED NETWORK OF AUTONOMOUS OFF GRID POWERED LIGHTING DEVICES WIRELESS ENVIRONMENT, LLC (US) 2016-08-25 US disclosed
CN-105859609-A Beta-lactamase inhibitor and process for preparing the same 明治制果药业株式会社 2016-08-17 CN disclosed
CN-105873930-A Novel bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors 费多拉制药公司 2016-08-17 CN disclosed
US-20160222425-A1 Materials and Methods for Producing 6-Carbon Monomers Synthase INV NYLON CHEMICALS AMERICAS, LLC 2016-08-04 US disclosed
US-9399049-B2 Antibacterial phage, phage peptides and methods of use thereof TECHNOPHAGE, INVESTIGACAO E DESENVOLVIMENTO EM BIOTECNOLOGIA, SA (PT) 2016-07-26 US disclosed
US-9394270-B2 Cytotoxin compounds and methods of isolation UNIVERSITY OF SOUTH FLORIDA (US) 2016-07-19 US disclosed
US-9392669-B2 Line protection and coupling circuit for switch sensing devices WIRELESS ENVIRONMENT, LLC (US) 2016-07-12 US disclosed
CN-102307722-B Method for controlling depolymerization of polymer compositions 罗地亚管理公司 2016-06-22 CN disclosed
US-9365851-B2 Spalt-like transcription factor 4 (SALL4) and uses thereof NATIONAL UNIVERSITY OF SINGAPORE (SG) 2016-06-14 US disclosed
WO-2016089677-A2 NOVEL QTL OF BRASSICA PLANT CORRELATED TO FATTY ACID PROFILE CARGILL, INCORPORATED (US) 2016-06-09 WO disclosed
CN-105505618-A Sulfonate group-containing copolymers and manufacturing method thereof PROCTER & GAMBLE 2016-04-20 CN disclosed
WO-2016044626-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2016-03-24 WO disclosed
US-20160074446-A1 Antibacterial Phage, Phage Peptides And Methods Of Use Thereof TECHNOPHAGE, INVESTIGACAO E DESENVOLVIMENTO EM BIOTECNOLOGIA, S.A. (PT) 2016-03-17 US disclosed
US-20160035762-A1 Methods for Manufacturing RFID Tags and Structures Formed Therefrom THIN FILM ELECTRONICS, ASA (NO) 2016-02-04 US disclosed
CN-103270055-B For the polymkeric substance of glass ionomer cement DENTSPLY DETREY GMBH (DE) 2016-01-20 CN disclosed
WO-2016006706-A1 PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYL METHYL GROUP 第一三共株式会社 2016-01-14 WO disclosed
EP-2089385-B1 INHIBITORS OF HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2016-01-06 EP disclosed
US-9220265-B2 Metalloenzyme inhibitor compounds VIAMET PHARMACEUTICALS, INC. (US) 2015-12-29 US disclosed
US-9222077-B2 Antibacterial phage, phage peptides and methods of use thereof Tecnifar—Industria Tecnica Farmaceutica, S.A. (PT) 2015-12-29 US disclosed
US-9212231-B2 TRAIL R2-specific multimeric scaffolds MEDIMMUNE, LLC (US) 2015-12-15 US disclosed
US-9205144-B2 Identification of conserved peptide blocks in homologous polypeptides DANA-FARBER CANCER INSTITUTE, INC. (US) 2015-12-08 US disclosed
US-20150279654-A1 TREATING SOLUTION FOR ELECTRONIC PARTS, AND PROCESS FOR PRODUCING ELECTRONIC PARTS FINE POLYMERS CORPORATION (JP) 2015-10-01 US disclosed
US-9120796-B2 B-lactamase inhibitor picoline salt CUBIST PHARMACEUTICALS, INC. (US) 2015-09-01 US disclosed
CN-102633580-B A kind of High-temperature acceleratingly-hardeemulsion emulsion explosive and preparation method thereof Anhui Jiangnan Chemical Industry Co., Ltd. Ningguo branch office (CN) 2015-08-12 CN disclosed
US-9057736-B2 Markers associated with arteriovascular events and methods of use thereof Health Diagnostics Laboratory, Inc. (US) 2015-06-16 US disclosed
US-9051372-B2 Anti-CD70 antibody and its use for the treatment of cancer and immune disorders SEATTLE GENETICS, INC. (US) 2015-06-09 US disclosed
EP-2877803-A2 SYSTEMS, STRUCTURES AND MATERIALS FOR ELECTRONIC DEVICE COOLING Outlast Technologies LLC (US) 2015-06-03 EP disclosed
US-20150144955-A1 Isolated Gate Field Effect Transistor and Manufacture Method Thereof DYNAX SEMICONDUCTOR, INC. (CN) 2015-05-28 US disclosed
US-9005630-B2 Fusion proteins for the treatment of allergic diseases VETERINAERINSTITUTTET (NO) 2015-04-14 US disclosed
US-20150094472-A1 B-LACTAMASE INHIBITOR PICOLINE SALT MERCK SHARP & DOHME CORP. 2015-04-02 US disclosed
US-8962021-B2 Solid pharmaceutical composition comprising telithromycin AVENTIS PHARMA SA (FR) 2015-02-24 US disclosed
CN-104334559-A Novel beta-lactamase inhibitor and process for preparing the same MEIJI SEIKA PHARMA CO LTD 2015-02-04 CN disclosed
EP-2500345-B1 8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXAMIDE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2015-01-28 EP disclosed
WO-2015002754-A2 NOVEL BICYCLIC BROMODOMAIN INHIBITORS ZENITH EPIGENETICS CORP. (CA) 2015-01-08 WO disclosed
US-20140363422-A1 METHOD OF PROVIDING MONOCLONAL AUTO-ANTIBODIES WITH DESIRED SPECIFICITY IMMUNOQURE AG (DE) 2014-12-11 US disclosed
WO-2014192868-A1 CYCLIC AMINOMETHYL PYRIMIDINE DERIVATIVE 大日本住友製薬株式会社 (JP) 2014-12-04 WO disclosed
WO-2014182538-A1 COMPOSITIONS AND METHODS FOR CHEMICAL EXCHANGE SATURATION TRANSFER (CEST) MAGNETIC RESONANCE IMAGING (MRI) THE JOHNS HOPKINS UNIVERSITY (US) 2014-11-13 WO disclosed
WO-2014160031-A1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2014-10-02 WO disclosed
US-20140288107-A1 METALLOENZYME INHIBITOR COMPOUNDS Viamet Pharmaceuticals (NC), Inc. 2014-09-25 US disclosed
US-20140194495-A1 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION THE UAB RESEARCH FOUNDATION (US) 2014-07-10 US disclosed
US-8710271-B2 Process for the production of an acylation catalyst BASF SE (DE) 2014-04-29 US disclosed
US-20140079671-A1 Antibacterial Phage, Phage Peptides And Methods Of Use Thereof TECHNOPHAGE, INVESTIGAÇÃO E DESENVOLVIMENTO EM BIOTECNOLOGIA, SA (PT) 2014-03-20 US disclosed
US-8669376-B2 Cytotoxin compounds and methods of isolation UNIVERSITY OF SOUTH FLORIDA (US) 2014-03-11 US disclosed
WO-2014018570-A1 CYSTATHIONINE-Υ-LYASE (CSE) INHIBITORS SOVA PHARMACEUTICALS, INC. (US) 2014-01-30 WO disclosed
WO-2014018491-A2 SYSTEMS, STRUCTURES AND MATERIALS FOR ELECTRONIC DEVICE COOLING Outlast Technologies, LLC (US) 2014-01-30 WO disclosed
WO-2013158746-A1 COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE BIOCRYST PHARMACEUTICALS, INC. (US) 2013-10-24 WO disclosed
US-8486987-B2 Mechanism-based small-molecule parasite inhibitors UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2013-07-16 US disclosed
CN-102492309-B Suspension type photo-thermal conversion organic phase change dye UNIV DALIAN TECH 2013-06-19 CN disclosed
EP-2591675-A1 Heteroaryl amide derivatives H. Lundbeck A/S (DK) 2013-05-15 EP disclosed
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
CN-102656186-A Therapeutic agents NUTRIPEP PTY LTD 2012-09-05 CN disclosed
CN-102633580-A High-temperature acceleratingly-hardened emulsion explosive and preparation method for same NINGGUO BRANCH OF ANHUI JIANGNAN CHEMICAL INDUSTRY CO LTD 2012-08-15 CN disclosed
CN-102492309-A Suspension type photo-thermal conversion organic phase change dye UNIV DALIAN TECH 2012-06-13 CN disclosed
US-8178559-B2 Organic compounds NOVARTIS AG (CH) 2012-05-15 US disclosed
US-20110263560-A1 Organic Compounds NOVARTIS AG (CH) 2011-10-27 US disclosed
CN-102197127-A Copolymer containing sulfonate group and preparation method thereof PROCTER & GAMBLE 2011-09-21 CN disclosed
EP-2231636-B1 PYRAZOLE DERIVATIVES AND USE THEREOF AS INHIBITORS OF CYCLIN DEPENDENT KINASES NOVARTIS AG (CH) 2011-09-14 EP disclosed
US-20110207003-A1 Method for removing CO, H2 and/or CH4 from the anode waste gas of a fuel cell with mixed oxide catalysts comprising Cu, Mn and optionally at least one rare earth metal SUD-CHEMIE AG (DE) 2011-08-25 US disclosed
WO-2011038086-A2 INDOLIZINE INHIBITORS OF 5-LIPOXYGENASE AMIRA PHARMACEUTICALS, INC. (US) 2011-03-31 WO disclosed
WO-2010147318-A2 AMINOANTHRACENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME 주식회사 두산 (KR) 2010-12-23 WO disclosed
WO-2010141499-A2 LIGNIN OXIDATION AND PRODUCTS THEREOF STRATEGIC ENZYME APPLICATIONS, INC. (US) 2010-12-09 WO disclosed
US-20100255465-A1 Nucleic Acid-Polymer Particle for and Method of Tracing Movement of a Liquid ENVIROGENE LTD. 2010-10-07 US disclosed
WO-2009151744-A1 S-NITROSOMERCAPTO COMPOUNDS AND RELATED DERIVATIVES GALLEON PHARMACEUTICALS, INC. (US) 2009-12-17 WO disclosed
WO-2009111354-A2 TYROSINE KINASE INHIBITORS TIGER PHARMATECH (US) 2009-09-11 WO disclosed
US-20090192215-A1 Cytotoxin Compounds and Methods of Isolation UNIVERSITY OF SOUTH FLORIDA (US) 2009-07-30 US disclosed
CN-101479214-A Composition for coloring ceramic articles GRAZIANO VIGNALI (IT) 2009-07-08 CN disclosed
EP-2029770-A2 A NUCLEIC ACID - POLYMER PARTICLE FOR AND METHOD OF TRACING MOVEMENT OF A LIQUID Envirogene, Ltd. (GB) 2009-03-04 EP disclosed
US-20080289631-A1 APPARATUS AND METHOD FOR RESPIRATORY TRACT THERAPY VAPOTHERM, INC. 2008-11-27 US disclosed
EP-1934196-A2 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION University of South Florida (US) 2008-06-25 EP disclosed
WO-2007148058-A2 A NUCLEIC ACID-POLYMER PARTICLE FOR AND METHOD OF TRACING MOVEMENT OF A LIQUID ENVIROGENE LTD (GB) 2007-12-27 WO disclosed
EP-1063227-B1 HYDRAZIDE FIXED TO RESIN AND DERIVATIVE THEREOF, AND METHOD FOR SYNTHESIZING PYRAZOLONES IN SOLID PHASE JAPAN SCIENCE & TECH AGENCY (JP) 2007-10-31 EP disclosed
US-7268199-B2 Use of alkoxylated polyvinyl amines for the modification of surfaces BASF AKTIENGESELLSCHAFT (DE) 2007-09-11 US disclosed
US-20070172930-A1 process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereof MEDICAL RESEARCH COUNCIL (ZA) 2007-07-26 US disclosed
EP-1801861-A1 METHOD AND DEVICE FOR TREATING OUTER PERIPHERY OF BASE MATERIAL SEKISUI CHEMICAL CO., LTD. (JP) 2007-06-27 EP disclosed
WO-2007056448-A2 ACCELERANTS FOR THE MODIFICATION OF NON-NATURAL AMINO ACIDS AND NON-NATURAL AMINO ACID POLYPEPTIDES AMBRX, INC. (US) 2007-05-18 WO disclosed
WO-2007035734-A2 CYTOTOXIN COMPOUNDS AND METHODS OF ISOLATION UNIVERSITY OF SOUTH FLORIDA (US) 2007-03-29 WO disclosed
US-20070004045-A1 Analysis of large numbers of estrogens and other steroids and applications thereof THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2007-01-04 US disclosed
US-20070004665-A1 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability SIRNA THERAPEUTICS, INC. (US) 2007-01-04 US disclosed
CN-1198849-C Method for prodn. of shaped hydrogel of absorbent resin NIPPON CATALYTIC CHEM IND (JP) 2005-04-27 CN disclosed
US-20030143908-A1 Use of alkoxylated polyvinyl amines for the modification of surfaces BASF AKTIENGESELLSCHAFT (DE) 2003-07-31 US disclosed
CN-1233617-A Method for prodn. of shaped hydrogel of absorbent resin NIPPON CATALYTIC CHEM IND (JP) 1999-11-03 CN disclosed
EP-0762196-B1 Heat developable light-sensitive material FUJI PHOTO FILM CO LTD (JP) 1999-10-27 EP disclosed
EP-0741320-A1 Photothermographic Photosensitive Recording Material with Hugh Gradient DU PONT DE NEMOURS (DEUTSCHLAND) GMBH (DE) 1996-11-06 EP disclosed
EP-0302284-B1 STABILIZED ENZYMES RAMOT UNIVERSITY, AUTHORITY FOR APPLIED RESEARCH &amp; INDUSTRIAL DEVELOPMENT LTD. (IL) 1992-09-30 EP disclosed
CN-1050191-A New thiazole derivative, they the preparation method and contain their pharmaceutical composition FUJISAWA PHARMACEUTICAL CO (JP) 1991-03-27 CN disclosed
EP-0360617-A2 Dry toner, dry developer and process for forming images Hitachi Chemical Co., Ltd. (JP) 1990-03-28 EP disclosed
CN-1040796-A The preparation method of fruylthiazole derivatives FUJISAWA PHARMACEUTICAL CO (JP) 1990-03-28 CN disclosed
US-4904592-A POLYALDEHYDE BASE COAT LINKED TO FREE AMINO GROUPS OF THE ENZYME AND CROSS-LINKED WITH POLYMER COAT RAMOT UNIVERSITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. (IL) 1990-02-27 US disclosed
US-4240980-A ACETYLATION OF N,N'-DIACETYLETHYLENEDIAMINE WITH ACETIC ANHYDRIDE HOECHST AKTIENGESELLSCHAFT (DE) 1980-12-23 US disclosed
US-4240980-A ACETYLATION OF N,N'-DIACETYLETHYLENEDIAMINE WITH ACETIC ANHYDRIDE HOECHST AKTIENGESELLSCHAFT (DE) 1980-12-23 US disclosed